InvestorsHub Logo
Followers 69
Posts 5360
Boards Moderated 0
Alias Born 12/27/2005

Re: JPetroInc post# 128360

Saturday, 06/16/2018 4:37:14 PM

Saturday, June 16, 2018 4:37:14 PM

Post# of 130502
Do you remember what the company paid for Eltoprazine?

Do you know what it's worth today?

Amarantus recently received an independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million.



In all the posts about dilution, it's never mentioned that the assets are worth more today than 4 years ago. A lot more.